Warby Parker Inc. (WRBY) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Warby Parker Inc. is a mission-driven lifestyle brand operating at the intersection of technology, design, healthcare, and social enterprise. The company sells eyewear products and provides optical services through its e-commerce platform and a network of 256 retail stores as of the period end. The company operates as a single operating segment.
Key Financial Metrics
| Metric | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Revenue | $188.2 million | $166.1 million | $388.2 million | $338.1 million |
| Gross Profit | $105.4 million | $90.6 million | $218.8 million | $185.4 million |
| Gross Margin | 56.0% | 54.6% | 56.4% | 54.8% |
| Net Loss | $(6.8) million | $(15.9) million | $(9.4) million | $(26.7) million |
| Adjusted EBITDA | $19.6 million | $14.2 million | $42.0 million | $31.9 million |
| Adjusted EBITDA Margin | 10.4% | 8.5% | 10.8% | 9.4% |
| Cash and Equivalents | $238.0 million | $212.7 million | $238.0 million | $212.7 million |
| Operating Cash Flow (YTD) | $51.6 million | $27.4 million | $51.6 million | $27.4 million |
Liquidity and Debt: The company holds $238.0 million in cash and cash equivalents. It maintains a $120.0 million revolving credit facility (2024 Credit Facility) with an option to increase capacity to $175.0 million. There were no borrowings outstanding under the facility as of June 30, 2024, other than $4.7 million in letters of credit used to secure leases.
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 13.3% year-over-year in Q2 2024, driven by a 4.5% increase in Active Customers (2.39 million) and an increase in Average Revenue per Customer to $302 (from $277). Growth was fueled by the adoption of precision progressives and bundling promotions.
- Margin Expansion: Gross margin improved by 140 basis points to 56.0%, attributed to faster growth in the high-margin glasses business, lower outbound shipping costs, and efficiencies in owned optical laboratories. This was partially offset by lower-margin contact lens sales growth and increased doctor salaries.
- Expense Management: Selling, General, and Administrative (SG&A) expenses increased 5.0% in absolute terms but decreased as a percentage of revenue (60.8% vs. 65.5%) primarily due to a $4.2 million reduction in stock-based compensation related to the Founders Grant.
- Profitability: Net loss narrowed significantly to $6.8 million from $15.9 million in the prior year quarter. Adjusted EBITDA improved to $19.6 million.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management expects operating losses to continue in the foreseeable future as the company invests in business expansion, including new retail stores and technology. They believe current cash and credit facilities are sufficient for at least the next 12 months.
- Material Weaknesses in Internal Controls: Management concluded that disclosure controls and procedures were not effective as of June 30, 2024, due to two material weaknesses: (1) IT general controls over key accounting systems, and (2) process controls regarding segregation of duties and manual journal entries. Remediation efforts are underway, including ERP implementation and hiring of SOX-experienced personnel.
- Litigation: The company reached an agreement in principle to settle wage and hour class action lawsuits for $1.95 million. The settlement is expected to be finalized in Q3 2024, and the full amount has been accrued.
- Investments: The company made a $2.0 million investment in a private optical equipment company in March 2024.
Key Facts for Investor Verification
- Internal Control Remediation: Verify the timeline and progress of remediation for the identified material weaknesses in IT and financial reporting controls, as these pose a risk to future financial statement accuracy.
- Stock-Based Compensation Volatility: Monitor the trajectory of stock-based compensation expenses, which decreased significantly in 2024 due to the Founders Grant vesting schedule but may fluctuate based on stock price hurdles for Performance Stock Units (PSUs).
- Store Expansion Costs: Assess the impact of opening new retail stores (256 total) on SG&A and depreciation, and whether the increased store count continues to drive the observed growth in Average Revenue per Customer.
- Settlement Finalization: Confirm the finalization of the $1.95 million litigation settlement and ensure no additional legal contingencies arise.